Si-Bone (SIBN) reported $201M in revenue for fiscal 2025, +20.2% year on year. That ranks #2660 by revenue among 2853 SEC filers and #284 in Healthcare. It posted a net loss of −$18.9M for the same year. Revenue has grown 19.6% a year on average since 2017 ($48.0M then). The fiscal 2025 balance sheet shows $239M in total assets, $42.2M in cash and $35.6M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $201M | +20.2% | FY20252025-12-31 |
| Gross profitGrossProfit | $160M | +21.0% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | −$22.3M | +$12.9M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$18.9M | +$12.0M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | −$675,000 | +$11.8M | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $8.4M | −19.8% | FY20252025-12-31 |
| Total assetsAssets | $239M | +3.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $178M | +6.3% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $42.2M | +20.9% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $35.6M | +0.3% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $52.6M | −$4.3M | Open → |
| Q2 20262026-06-30 | $56.0M | −$4.1M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Si-Bone, Inc.
- Ticker
- SIBN
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001459839
Filings
- 10-QAug 4, 2026Open filing →
- 10-QMay 11, 2026Open filing →
- 10-KFeb 24, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Treace Medical ConceptsTMCI | $213M | −$59.0M |
| Establishment LabsESTA | $211M | −$51.1M |
| Canopy GrowthCGC | $204M | −$189M |
| Si-BoneSIBN | $201M | −$18.9M |
| ValnevaVALN | $197M | −$130M |
| Strata Critical MedicalSRTA | $197M | $41.3M |
| LifemdLFMD | $194M | −$11.2M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Si-Bone — Key figures |url=https://companiesranked.com/en/company/si-bone |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Si-Bone — Key figures. CompaniesRanked. https://companiesranked.com/en/company/si-boneBibTeX
@misc{companiesranked-en-company-si-bone-2026,
author = {{CompaniesRanked}},
title = {{Si-Bone — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/si-bone}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001459839-26-000036 · February 24, 2026
{{cite web |title=Si-Bone — Key figures — 10-K (0001459839-26-000036) |url=https://www.sec.gov/Archives/edgar/data/1459839/000145983926000036/sibn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.